China SXT Pharmaceuticals, Inc. (SXTC) Capital expenditures 2018–2026
China SXT Pharmaceuticals, Inc. (SXTC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2,023FY2026 · since FY2018: $179,176 → $2,023
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $2,023 | -71.4% |
| FY2025 | $7,063 | — |
| FY2021 | $130,839 | -75.6% |
| FY2020 | $535,825 | +22.9% |
| FY2019 | $436,017 | +143.3% |
| FY2018 | $179,176 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice